ethyl 1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate
![ethyl 1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate price.](/CAS2/GIF/1193386-52-5.gif)
|
- $535 - $632
- Product name: ethyl 1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate
- CAS: 1193386-52-5
- MF: C15H17ClN2O3
- MW: 308.76
- EINECS:
- MDL Number:MFCD12032190
- Synonyms:ethyl 1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate;Ethyl 1-(5-chloro-1,3-benzoxazol-2-yl)piperidine-4-carboxylate;4-Piperidinecarboxylic acid, 1-(5-chloro-2-benzoxazolyl)-, ethyl ester
3 prices
Selected condition：
Brand
- Chemenu
- Crysdot
Package
- 100mg
- 1g
- ManufacturerChemenu
- Product numberCM159577
- Product descriptionethyl1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate 95%
- Packaging1g
- Price$632
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11334771
- Product descriptionEthyl1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate 95+%
- Packaging100mg
- Price$535
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11334771
- Product descriptionEthyl 1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate 95+%
- Packaging100mg
- Price$535
- Updated2026-05-27
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM159577 | ethyl1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate 95% | 1g | $632 | 2021-12-16 | Buy |
| Crysdot | CD11334771 | Ethyl1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate 95+% | 100mg | $535 | 2021-12-16 | Buy |
| Crysdot | CD11334771 | Ethyl 1-(5-chlorobenzo[d]oxazol-2-yl)piperidine-4-carboxylate 95+% | 100mg | $535 | 2026-05-27 | Buy |
Properties
Boiling point :422.4±55.0 °C(Predicted)
Density :1.297±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :1.41±0.10(Predicted)
Density :1.297±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :1.41±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|